A review on Pushkarmula - The effective Anti-Ischemic Drug
Abstract
Hridroga is a disease of Marma (vital organ) which is the seat of many vital activities. In Ayurveda all the painful heart disease comes under the broad classification of Hridroga. In modern science myocardial ischemia is one of the worst painful conditions among the heart diseases Myocardial ischemic develops when Coronary blood supply to the myocardium is reduced, either in terms of absolute flow rate. (Low-flow or no flow ischemia) or relative to increased tissue demand. Inula racemosa Hook, F (Asteraceae) Commonly known as Pushkarmula is one of the herbs mentioned in all Ayurvedic scriptures. The great Sage Charaka has categorized it as Hikkanigrahana - stops hiccup a Svasahara - alleviates the breathlessness in asthma. It has also anti-inflammatory, Cardiovascular hypoglycemic, antianginal, analgesic and antibacterial Properties. This article is an attempt to collect and review all the data concerning systemic scientific study of ethnopharmacology of Inula racemosa and its cardio protective functions.
Downloads
References
PG Aathavale. Sushrut Samhita, Uttara Tantra, Hridrogpratishedh Adhyaya, 43/4. Chaukhamba Sanskrit Sansthan, Varanasi. 2nd edition, 2002;pp259.
Charaka Samhita, Sutra Sthana, Astodariyam Adhyaya,19/4,
Singh, R.; Singh, R.; Batliwala, P.; Upadhyay, B.; Tripathi, S., Puskara-Guggulu, an Anti-anginal and Hypolipidemic Agent in Coronary Heart Diseases (CHD). Jour. Res. Ay. & Siddha 1991,12.
Review Article www.ijrap.netETHNOPHARMACOLOGY, PHYTOCHEMISTRY AND BIOLOGICAL ACTIVITY OF INULA RACEMOSA HOOK. F: A REVIEWQurba Firdous 1 MohammadFaizan Bhat 2, Mubashir Hussain M 3
A textbook of dravyagunavijnyan part 1 and 2 by Dr. A.P. Deshpande proficient publishing house
Charak Samhita with cakrapanidata commentary ayurveddipika by vd. Harishchandra Kushwaha chaukhabhaorientaliyachikitsaadhyay 26 sutra 83
Charak Samhita with cakrapanidata commentary ayurveddipika by vd. Harishchandra Kushwaha chaukhabhaorientaliyachikitsaadhyay 26 sutra 85
Charak Samhita with cakrapanidata commentary ayurveddipika by vd. Harishchandra Kushwaha chaukhabhaorientaliyachikitsaadhyay 26 sutra 97
Bhavaprakasa of sribhamisra edited with vidyotinihindicommentars notes introduction index etc.by bhisagratna pandit sri brahma sankaramisra part2 chaukhambha Sanskrit bhawan Varanasi 221001(india)
chakradatta of sricakrapanidatta with the padarthabodhinihindi commentary by Vaidya ravidatta shastri chaukhambasurbharatiprakashan Varanasi hadrogadhikar 30 sutra 12
chakradatta of sricakrapanidatta with the padarthabodhinihindi commentary by Vaidya ravidatta shastri chaukhambasurbharatiprakashan Varanasi hadrogadhikar 30 sutra17
chakradatta of sricakrapanidatta with the padarthabodhinihindi commentary by Vaidya ravidatta shastri chaukhambasurbharatiprakashan Varanasi hadrogadhikar 30 sutra 20-21
vangasena Samhita chikitsasarsangrahhindivyakhyakardr Rajeev kumar ray prachy prakashan Varanasi hrdyarogadhikar sutra9
vangasena Samhita chikitsasarsangrahhindivyakhyakardr Rajeev kumar ray prachy prakashan Varanasi hrdyarogadhikarsutra 27
vangasena Samhita chikitsasarsangrahhindivyakhyakardr Rajeev kumar ray prachy prakashan Varanasi hrdyarogadhikar sutra 42
vangasena Samhita chikitsasarsangrahhindivyakhyakardr Rajeev kumar ray prachy prakashan Varanasi hrdyarogadhikar sutra 47
International Journal of Basic and Applied Sciences. Vol. 7 No. 3. 2018. Pp. 89-91
Copyright (c) 2022 Sapana S. Dakhole, Brijesh R. Mishra, Harish J. Purohit
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.